


Healthcare Industry News: HIV/AIDS
News Release - June 14, 2007
Boehringer Ingelheim Initiates SPRING Study of Aptivus(R) (tipranavir) capsules in Diverse Group of Highly Treatment-Experienced HIV Patients
Source: Boehringer Ingelheim
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
